| Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. | None |
| Functional analysis of the VHL tumor suppressor gene promoter sheds light on the developmental regulation of VHL expression, molecular pathology of epigenetic silencing of VHL in tumorigenesis, and suggests a link between Sp1, VHL, and nephrogenesis. | None |
| The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1. | None |
| Review. The von Hippel-Lindau tumor suppressor protein regulates hypoxia-inducible gene transcription. It is a subunit of an E3 ubiquitin ligase targeting HIFalpha subunits. | None |
| Tyrosine hydroxylase promoter activity is regulated by the von Hippel-Lindau tumor suppressor protein and HIF1alpha and HIF2alpha in PC12 cells | None |
| The Hsp70 and TRiC/CCT chaperone systems cooperate in vivo to assemble the von Hippel-Lindau tumor suppressor complex. | None |
| the subcellular localization of VHL plays a role in its tumor suppressor properties | None |
| Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. | None |
| The von Hippel-Lindau tumour suppressor protein pVHL negatively regulates CXCR4 expression owing to its capacity to target hypoxia-inducible factor (HIF) for degradation under normoxic conditions | None |
| A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred. | None |
| von Hippel-Lindau tumor suppressor protein is a molten globule under native conditions | None |
| Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. | None |
| von Hippel-Lindau tumor suppressor: not only HIF_s executioner. | None |
| The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery. | None |
| A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis. | None |
| A DNA sequence analysis of vhl tumor suppressor gene revealed the L163R mutation. This new mutation may be specifically associated with the von Hippel-Lindau type 2C disease phenotype. | None |
| von Hippel-Lindau tumour suppressor protein regulates HIF-1alpha and its oxygen-regulated transactivation domains at high cell density. | None |
| mechanisms of VHL tumour suppressor function and novel hypoxia-responsive genes that might be implicated in tumorigenesis in both VHL disease and in other cancers | None |
| The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting. | None |
| the association of the elongin-binding domain of the tumor suppressor protein vin Hippel Landau (VHL) with a specific RNA-binding domain of HuR (RRM1) is important for the destabilizing function of VHL on VPF/VEGF mRNA | None |